Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 1998, p. 567-573, Vol. 5, No. 4
Department of
Microbiology1 and
Department of
Biological Resources Engineering,4 University of
Maryland, and
Virginia-Maryland Regional College of
Veterinary Medicine,5 College Park, Maryland
20742;
Kirkegaard and Perry Laboratories, Gaithersburg,
Maryland 208792; and
Enteric
Diseases Program, Naval Medical Research Institute, Bethesda,
Maryland 208893
Received 20 January 1998/Returned for modification 25 February
1998/Accepted 22 April 1998
E. coli O157:H7 is a food-borne adulterant that can
cause hemorrhagic ulcerative colitis and hemolytic uremic syndrome.
Faced with an increasing risk of foods contaminated with E. coli O157:H7, food safety officials are seeking improved
methods to detect and isolate E. coli O157:H7 in hazard
analysis and critical control point systems in meat- and
poultry-processing plants. A colony lift immunoassay was developed to
facilitate the positive identification and quantification of E. coli O157:H7 by incorporating a simple colony lift enzyme-linked
immunosorbent assay with filter monitors and traditional culture
methods. Polyvinylidene difluoride (PVDF) membranes (Millipore,
Bedford, Mass.) were prewet with methanol and were used to make
replicates of every bacterial colony on agar plates or filter monitor
membranes that were then reincubated for 15 to 18 h at 36 ± 1°C, during which the colonies not only remained viable but were
reestablished. The membranes were dried, blocked with blocking buffer
(Kirkegaard and Perry Laboratories [KPL], Gaithersburg, Md.), and
exposed for 7 min to an affinity-purified horseradish
peroxidase-labeled goat anti-E. coli O157 antibody (KPL).
The membranes were washed, exposed to a 3,3',5,5'-tetramethylbenzidine membrane substrate (TMB; KPL) or aminoethyl carbazole (AEC; Sigma Chemical Co., St. Louis, Mo.), rinsed in deionized water, and air
dried. Colonies of E. coli O157:H7 were identified by
either a blue (via TMB) or a red (via AEC) color reaction. The colored spots on the PVDF lift membrane were then matched to their respective parent colonies on the agar plates or filter monitor membranes. The
colony lift immunoassay was tested with a wide range of
genera in the family Enterobacteriaceae as well as
different serotypes within the E. coli genus. The
colony lift immunoassay provided a simple, rapid, and accurate method
for confirming the presence of E. coli O157:H7 colonies
isolated on filter monitors or spread plates by traditional culture
methods. An advantage of using the colony lift immunoassay is the
ability to test every colony serologically on an agar plate or
filter monitor membrane simultaneously for the presence of the E. coli O157 antigen. This colony lift immunoassay has recently
been successfully incorporated into a rapid-detection, isolation, and
quantification system for E. coli O157:H7, developed in our
laboratories for retail meat sampling.
Escherichia coli O157:H7,
associated with 34 reported food-borne outbreaks between 1982 and 1993 in the United States, has become recognized as a potentially lethal
food-borne pathogen (4). While ground beef is
the most common source of infection for E. coli O157:H7 in
the United States, point source outbreaks have been traced to a
variety of different foods. Some of these associated foods (e.g.,
apple cider and mayonnaise) illustrate the remarkable osmo- and acid
tolerance properties of E. coli O157:H7 (21).
This organism was first recognized in the United States but has been
determined to be an epidemiologically significant cause of food-borne
disease worldwide. The largest reported outbreaks (May and July of
1996), which involved 6,500 cases and 11 fatalities, occurred in Japan
(2, 24). More recently, another O157:H7 outbreak in Scotland
infected 260 people and caused 17 fatalities (7, 18). The
largest recall of food product contaminated with E. coli
O157:H7 occurred in the summer of 1997, when 25 million lb of hamburger
meat was recalled by a single meat-processing company
(3).
The low infectious dose ( In response to the health risks associated with food contaminated with
E. coli O157:H7, the U.S. Department of Agriculture is
implementing hazard analysis and critical control points (HACCP) in
existing production and processing procedures to reduce or eliminate
contamination. HACCP is a management program intended to facilitate and
verify the implementation of effective practices that prevent the
spread of food-borne disease from farms to consumers. Compliance with
HACCP legislation will require on-site sampling and laboratory testing
to measure the reduction and determine the elimination of pathogen
contamination in any given facility. Immediate reduction in the
prevalence and quantity of microbiological pathogens in food is the
contemporary concern.
Incorporating and monitoring HACCP programs is not a trivial task for
meat and poultry plants, although those facilities that already have
microbial intervention methods on-line will find the requirements less
daunting. Issues of expense and convenience for industry must be
balanced with reliable methods for satisfying HACCP regulations. As
qualitative methods that are designed to detect specific microbial
pathogens become less expensive and easier to use with new technology,
they will undoubtedly have a role in monitoring food safety by enabling
greater detection capability.
However, the importance and benefits of quantifying these pathogens
should be very seriously considered when we attempt to understand the
dynamics of contamination, a prime prerequisite in establishing logical
and effective HACCP programs. Quantification methods are beneficial
because they (i) can be used to determine the efficacy of HACCP
intervention protocols in reducing pathogen contamination, (ii) will
allow for comparison to national baseline data once it has been
collected and assessed, and (iii) provide data for risk assessment and
epidemiological studies. Current quantification techniques for
E. coli O157:H7, such as direct plating and the most
probable number technique, are not as cost-effective or efficient as
qualitative methods such as enzyme-linked immunosorbent assay-based
systems (16, 23), PCR-based assays (9), DNA probe
systems (17), and immunomagnetic separation (25).
However, none of these qualitative methods can replace the
aforementioned benefits inherent in a quantitative system.
The colony lift immunoassay (CLI), a novel method for rapid
immunodetection and enumeration of target pathogens following specimen
preparation, has been applied to enterohemorrhagic E. coli O157:H7. The CLI, when used in conjunction with a selective and differential medium, enables the detection, confirmation, and
quantification of E. coli O157:H7 organisms
after the colonies are isolated onto agar or filter monitor
membranes with high sensitivity (100%) and specificity (88.9%), based
on the data derived from this study (Table
1).
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Development of a Colony Lift Immunoassay To Facilitate Rapid
Detection and Quantification of Escherichia coli O157:H7
from Agar Plates and Filter Monitor Membranes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
10 CFU) of this organism and its ability to
cause any one illness or all illnesses of a devastating disease triad
(hemorrhagic ulcerative colitis, hemolytic uremic syndrome, and
thrombotic thrombocytopenic purpura) (15, 22) has
prompted the U.S. Food Safety Inspection Service (FSIS; Athens, Ga.) to establish a zero-tolerance threshold for E. coli O157:H7 contamination of raw meat products (1).
Any level of contamination with E. coli O157:H7 is
considered adulterating.
TABLE 1.
Specificities of the HRP-labeled goat anti-E.
coli O157:H7 antibody and reaction of Rainbow O157 agar in
CLIs with 39 E. coli O157:H7 isolates, 54 miscellaneous E. coli serotypes, and other
enteric bacteria
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Maintenance and characterization of bacterial strains. The E. coli strains of various serotypes used in this study were obtained from various sources worldwide (Table 1). We also used other enteric genera isolated from local retail beef and poultry, as well as strains from the American Type Culture Collection (Rockville, Md.) The E. coli isolates were subcultured (37°C, 15 to 18 h) onto nutrient agar (Difco, Detroit, Mich.) and confirmed biochemically and serologically in accord with the U.S. Department of Agriculture-FSIS methods (15). Briefly, these methods employ the following tests and media: triple sugar iron, sorbitol, cellobiose and lactose fermentation, methyl red, Voges-Proskauer, indole, lysine and ornithine decarboxylase, Simmon's citrate, motility, and O157 and H7 slide agglutination tests (Difco). Non-Escherichia isolates of the family Enterobacteriaceae were analyzed with API 20E test strips (BioMerieux Vitek, Inc., Hazelwood, Mo.) according to the manufacturer's instructions. All isolates used in this study were subcultured (15 to 18 h, 37°C) and maintained (3 to 4 months, 4°C) on nutrient agar slants in closed, screw-cap tubes.
Culture preparation.
For this study, each isolate was grown
in 25 ml of sterile Trypticase soy broth (Difco) for 15 to 18 h at
36 ± 1°C. The cultures were pelleted at 3,000 rpm for 15 min at
4°C (Sorvall R4B centrifuge), resuspended in 4.0 ml of buffered
peptone water (Difco), and adjusted to 50% transmittance (T) on a
Spectronic-20 spectrophotometer (Milton Roy, Orange, Calif.). The
50%-T culture was diluted to 10
5, from which 100 µl
was inoculated onto a surface-dried nutrient agar plate by the spread
plate method and incubated for 15 to 18 h at 36 ± 1°C.
This technique consistently produced approximately 150 well-isolated
colonies for each of the isolates when they were grown on either
nutrient agar, sorbitol MacConkey's agar (SMAC; Difco), or 202 agar
(6).
Membrane evaluation. Three types of protein binding membranes were evaluated: (i) Immobilon-P polyvinylidene difluoride (PVDF) hydrophobic membranes (0.45-µm pore size; Millipore); (ii) Zeta-Probe, a nylon membrane (0.45-µm pore size; Bio-Rad, Hercules, Calif.); and (iii) Hybond-ECL, a nitrocellulose membrane (0.45-µm pore size; Amersham, Arlington Heights, Ill.). Each membrane type was cut into 4- by 1.5-cm strips. The PVDF strips required prewetting. They were saturated in 100% methanol, lightly tamped on a paper towel (to remove excess methanol), and placed while slightly damp on the surfaces of plates containing isolated colonies. After gentle pressure was applied with the wide end of a 200-µl micropipette tip to ensure antigen transfer, the PVDF membranes were removed and air dried. The other types of membranes (Zeta-Probe and Hybond-ECL) were not treated with methanol before antigen transfer. Each membrane was processed according to both the empirical and, eventually, the optimized CLI protocol (Fig. 1).
|
Antiserum preparation.
The antibody consisted of a
polyclonal, affinity-purified horseradish peroxidase (HRP)-labeled goat
anti-E. coli O157:H7 globulin (Kirkegaard and
Perry Laboratories [KPL], Gaithersburg, Md.). The preliminary
screening of all cultures (Table 1) used the following empirical
conditions: 1 µg of antibody ml
1, a 4-min conjugate
exposure time, and a 1-min substrate exposure time. The
membranes were developed by using a one-component
3,3',5,5'-tetramethylbenzidine substrate (KPL). In later
experiments, aminoethyl carbazole (AEC; Sigma Chemical Co., St. Louis,
Mo.) was used according to the manufacturer's instructions.
Agar medium evaluation. The agar media that were evaluated for efficacy with the CLI included nutrient agar, SMAC, 202 agar (6), and Rainbow O157 agar (BIOLOG, Inc., Hayward, Calif.). Each medium was evaluated for its use (i) in growing E. coli O157:H7, (ii) in differentiating the O157 serotype from those of other genera and from other E. coli serotypes, and (iii) as a platform from which the colonies could be lifted.
Determination of optimal conditions for the CLI. (i) Optimal
antibody concentration.
Seven PVDF membranes (circular, 83-mm
diameter with handles) were soaked in 100% methanol. Five
different O157:H7 strains (MDL 1 to 5) and four non-O157
E. coli strains (T884, 23848, PB6472, and M1712-1) were
directly inoculated with sterile loops onto sections of the
surfaces of damp membranes. After the membranes were dried, each
was exposed to one of seven different antibody concentrations
(0.5, 0.25, 0.125, 0.062, 0.031, 0.016, and 0.008 µg
ml
1) for 4 min and developed for 1 min with exposure to
3,3',5,5'-tetramethylbenzidine.
(ii) Optimized conditions for CLI.
Twenty-eight circular
PVDF membranes were soaked in 100% methanol and, while still damp,
were used to lift colonies from nutrient agar spread plates. Each
membrane contained well-defined colonies of one of four different
strains of E. coli: O157:H7 (MDL 4 and MDL 5), O157:H45
(KPL 300389), and O157:H3 (KPL 300489). Each membrane was dried,
blocked, and cut into seven symmetrical wedges. One representative
wedge (containing several CFU) of each E. coli strain
was placed into one of 28 125-ml sterile polypropylene sample
containers with screw-cap lids (Fisher Scientific, Pittsburgh, Pa.).
Twenty-eight sample containers were arranged into four rows (representing antibody concentrations 0.15, 0.1, 0.05, and 0.01 µg
ml
1) and seven columns (representing the conjugate
incubation times 1, 3, 6, 9, 12, 15, and 20 min). A 4 row by 7 column checkerboard analysis (Fig. 2) was
performed under standard conditions as described below (Fig. 1) for
each reaction container.
|
(iii) Determination of the minimum concentration of antigen
needed for a positive reaction.
An overnight Trypticase soy broth
culture of O157:H7 (MDL 7) was pelleted, resuspended, and adjusted to
50% T as described above. The 50%-T culture was diluted to
10
6 in buffered peptone water by using 10-fold dilutions.
For quantification, 100 µl from each dilution was spread plated onto
each of three nutrient agar plates. Similarly, 5 µl from each
dilution was pipetted onto a designated section of a methanol-dampened
PVDF membrane, which was then processed through the optimized CLI
protocol (Fig. 1).
(iv) CLI protocol.
Circular (83-mm-diameter) Immobilon-P
PVDF membranes (Millipore) were saturated with 100% methanol.
While still damp, the membranes were laid on the surfaces of agar
plates (Fig. 3) or filter monitor
membranes (Fig. 4) containing
presumptively positive E. coli O157:H7 colonies and
tamped lightly with the wide end of a 200-µl pipette tip to ensure
antigen transfer to the membrane. Single loopfuls of pure E. coli O157:H7 broth-grown cells were placed on the backs of the
membranes to serve as positive controls. The PVDF membranes were then
placed on a paper towel until they dried (10 to 15 min) and then
transferred to blocking buffer consisting of either a commercially
prepared solution (KPL) or 3% bovine serum albumin plus 0.02% Tween
20 (Sigma Chemical) suspended in phosphate-buffered saline (Sigma
Chemical). The membranes were exposed for 7.5 min in blocking buffer
containing 0.05 µg of the affinity-purified polyclonal HRP
anti-E. coli O157:H7 antibody (KPL) ml
1.
The membranes were then washed three times for 4 min each time in a
commercially prepared washing solution (KPL). Finally, the membranes
were exposed to AEC, an HRP conjugate substrate, for 2 to 10 min, after
which the reaction was stopped by rinsing the membranes in deionized
water. The AEC exposure time was determined by observing the AEC
reaction on the positive control spot. The membranes were air dried for
30 to 60 min before they were read. A replicate of the positive
reactions was made on a transparency or the lid of a petri dish by
marking the positive reactions with a felt tip marker. The replicate
could then be flipped onto the original spread plate or filter membrane
to match the CLI-positive replicate with the corresponding target
E. coli O157:H7 colony.
|
|
| |
RESULTS |
|---|
|
|
|---|
Evaluation of antibody specificity under the empirical CLI
conditions.
The initial trials to determine the specificity of the
antibody were performed with each strain described in Table 1. These strains were tested under empirical conditions (1 µg of antibody ml
1, 4-min conjugate exposure) as a starting point for
determining the optimal conditions for the CLI. The CLI specificity was
poor under these empirical conditions, producing a false-positive
reaction to 42% (n = 19) of the non-O157:H7
E. coli isolates (four O169:H40 strains [FK-1, OS-2,
KS-1, and OS-1], one O157:H45 strain [KPL 300389], one O157:H3
strain [KPL 300489], and two miscellaneous non-O157
E. coli strains [T884 and PB6472]). However, these
initial results provided a baseline from which the antibody
concentration and incubation time were optimized.
Selection of membrane and medium evaluation. Three types of membranes were evaluated on the basis of substrate color retention, durability, and ease of use. The PVDF membranes proved superior for use in the CLI. Antigen transfer from the petri plates or filter membranes was possible only once the PVDF membranes were moistened with 100% methanol, which temporarily neutralized the hydrophobic properties of the membrane. This membrane phenomenon greatly increased the efficiency of the CLI protocol, as many membranes could be processed in the same reaction chamber without antigen cross-contamination between the membranes. Because the PVDF membranes were easy to use, were much more durable than the nitrocellulose membranes, and had better color retention than the Zeta-Probe membranes, the PVDF membranes were used for optimizing the CLI procedure.
The solid media were evaluated for their ability to serve as a platform from which bacterial antigen could be transferred to the PVDF membranes during the CLI procedure. Effective antigen transfer was based on three characteristics, the first being the ability to support the growth of E. coli O157:H7 to produce enough antigenic mass for visualization by the CLI, the second being the ability of the PVDF membranes to bind antigen from the agar surface without discoloration of the membranes, and the third being the ability of some bacterial cells to remain viable on the agar surface for further characterization. Coloration of the PVDF membranes by anything other than the substrate reaction is undesirable, because contaminating substances may interfere with interpretation of the CLI results. The 202 agar imbued a blue-green color to many non-sorbitol-fermenting colonies (including typical O157:H7) and discolored the PVDF membranes during the antigen transfer step, but this discoloration was eliminated during the washing step in the CLI procedure. Levels of growth of E. coli O157:H7 on nutrient agar, SMAC, and 202 agar were comparable (data not shown), and the CLI methodology showed equivalent results with each type of medium. Because the antibody is not 100% specific for the H7 antigen (Table 1), we used a new medium (Rainbow O157 agar; BIOLOG, Inc.) to chromogenically differentiate O157:H7 strains (black) from non-O157:H7 strains (various shades of violet or blue) of E. coli. The chromogenicity is based on the two enzymes glucuronidase and galactosidase. Strains that were previously confirmed as either E. coli O157:H7 or E. coli O157:NM by biochemical and serological methods turned black on Rainbow O157 agar and were positive by the CLI assay.Optimal antibody concentration.
The preliminary study to
determine the optimal concentration of the HRP-labeled goat
anti-E. coli O157:H7 antibody concentration was
designed to reveal the intended effects of extreme antibody concentrations (false-positive and false-negative reactions) in the CLI
protocol. The substrate reactions were very weak and gradually faded
beyond recognition with antibody dilutions greater than or equal to
0.03125 µg ml
1 (data not shown). The antibody
concentration that worked best in the preliminary investigation of a
single incubation time was 0.0625 µg ml
1, based on
substrate color retention for the true positives and the absence of
substrate color for the true negatives.
1. Optimal antibody
concentration and exposure time combinations were those that gave the
darkest (strongest) substrate reaction for the E. coli
O157:H7 strains and the lightest (weakest) substrate reactions for the
E. coli O157:non-H7 strains.
Optimal antibody concentration and incubation time.
It was
determined that the optimal conditions for the CLI assay were 0.05 µg
of HRP-labeled goat anti-E. coli O157:H7 antibody (KPL)
ml
1 with a 6- to 9-min conjugate incubation (with an
average time of 7.5 min). These conditions were used to further screen
39 E. coli O157:H7, 24 E. coli
non-O157, and 10 E. coli O157:non-H7 isolates (Table
1). The CLI assay produced true-positive recognition of 100% (39 of
39) of the O157:H7 isolates, false-positive recognition of 100% (10 of
10) of the E. coli O157:non-H7 isolates, and
false-positive recognition of 4.1% (1 of 24) of the E. coli non-O157 isolates tested.
Determination of minimum antigen needed for a positive CLI. The CLI procedure is very sensitive and requires minimal antigen to obtain a positive reaction. Roughly 750 cells of E. coli O157:H7 suspended in 5 µl of 0.85% saline were distributed in a 1.0-mm2 spot onto a methanol-dampened PVDF membrane. The antigen produced a visible reaction after the CLI procedure was performed. Similarly, the CLI reaction on spread plates with pure cultures incubated for less than 5 h were positive in the absence of visible colonies on the culture medium.
| |
DISCUSSION |
|---|
|
|
|---|
A CLI for the detection and quantification of E. coli O157:H7 was successfully developed, optimized, and evaluated. Optimization involved the determination of the appropriate membrane and substrate types, antibody concentration, and exposure time. PVDF membranes (Millipore) were selected for use with the CLI, because of their durability, ease of use, and good retention of the substrate color reaction. Furthermore, once saturated in methanol, the hydrophobic PVDF material appeared to have a higher affinity for the protein (antigen) attachment. The antigen transfer step, however, had to be performed while the PVDF membrane was still moist with 100% methanol. Up to 20 membranes could be processed in a single reaction mixture with little risk of antigen cross-contaminating the membranes. The brief exposure of the colonies to methanol on the agar surface did not adversely affect their viability, which allowed subculturing for biochemical and serological testing and storage.
Available detection methods for E. coli O157:H7 focus on several characteristics that distinguish the O157:H7 strain from other serotypes of E. coli. For example, most O157:H7 strains lack the enzyme glucuronidase, in contrast to an estimated 94 to 97% of other E. coli strains that have the enzyme (13). Another distinction is that approximately 95% of all E. coli strains tested ferment D-sorbitol within 24 h, while E. coli O157:H7 is a slow sorbitol fermenter (8). Various culture media that use a combination of these and other biochemical tests to differentiate E. coli O157:H7 from other E. coli strains have been described (5, 8, 19, 20). While the importance of the primary selective plating media for screening is recognized, there is an increasing need for more efficient, rapid, and quantitative detection of E. coli O157:H7. Despite the concern for better methodology in the United States, primary culture techniques using basic SMAC are still the most commonly used methods for the detection and isolation of E. coli O157:H7.
The increasing significance of both variant O157:H7 strains and non-O157 enterohemorrhagic E. coli isolates as determinants of food-borne disease worldwide has focused much attention on rapid diagnostic methods that can detect these emerging strains as well as O157:H7 (10, 11, 17). In recognition of the fact that traditional culture methods are currently the most often used methods for detecting E. coli O157:H7, the CLI was developed to enhance the efficacy, sensitivity, and specificity of traditional culture systems. One benefit of incorporating the CLI into traditional culture systems for E. coli O157:H7 is the ability to screen all presumptively positive colonies (i.e., sorbitol-negative colonies) on a spread plate simultaneously for the presence of the E. coli O157 antigen. This advantage allows the CLI assay to be easily used as a quantification tool when it is performed on several spread plates per sample. The sensitivities of currently used quantification methods such as the most probable number technique could be improved in the confirmation step by replacing the five-colony pick method with the CLI procedure.
Most commercially available enzyme-linked immunosorbent assays incorporate a polyclonal E. coli O157:H7 antibody instead of a monoclonal alternative, perhaps because of the ease and low cost of preparation of the polyclonal antibody, the inability of the monoclonal antibody to achieve a significant increase in specificity, and the retention of greater sensitivity with the polyclonal antibody. Because polyclonal antibodies have been shown to be more sensitive than monoclonal antibodies, while retaining specificity, we decided to use a polyclonal affinity-purified HRP-labeled goat anti-E. coli O157:H7 antibody (KPL). This antibody has been shown to be reactive to E. coli O157:H7 and specific for the O157 lipopolysaccharide antigen (Fig. 1).
Rainbow O157 agar (BIOLOG, Inc.), a new selective and differential medium, was incorporated into the SELeCT system (14) (an acronym for a diagnostic system of isolation, identification, and detection of Salmonella spp., E. coli O157:H7, Listeria monocytogenes, and Campylobacter spp. in raw red meat and poultry) of isolation and identification of E. coli O157:H7 in foods to enhance the specificity for E. coli O157:H7. The selective properties of this medium prevented most non-E. coli organisms from growing, and its unique chromogenic properties differentiated the O157:H7 strain from other serotypes of E. coli (Table 1), thus increasing the specificity for detecting E. coli O157:H7 from 75.9 to 88.9%. Thus, the biochemical activity of the agar medium combined with the serological response essentially provided assurance of identification. Further confirmation was obtained with slide agglutination antiserum, which is an option for excluding possible false-positive strains. Actually in this instance, only H7 antiserum is required (8, 12). Rainbow O157 agar was not found to be inhibitory to any E. coli O157:H7 strains in quantitative comparison studies with Trypticase soy agar, 202 agar, and SMAC (data not shown).
In summary, the CLI is an effective and efficient method for detecting and quantifying E. coli O157:H7 on solid media and when used in conjunction with the E. coli SELeCT system (14), it can be used to detect and quantify less than 1 CFU/g in a 25-g red meat or poultry sample within 24 h. While the CLI has been shown to detect viable colonies of E. coli O157:H7 from spread plates following as few as 5 h of incubation under optimal growth conditions, the specificity of the test for E. coli O157:H7 with this shortened incubation period is yet to be determined.
| |
ACKNOWLEDGMENT |
|---|
This work was supported by U.S. Department of Agriculture contract FSIS-15-W-94.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Enteric Diseases Laboratory, Department of Microbiology, University of Maryland at College Park, College Park, MD 20742. Phone: (301) 405-5452. Fax: (301) 314-9489. E-mail: SJ13{at}umail.umd.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | American Association for Food Hygiene Veterinarians. 1996. FSIS publishes final rule on pathogen reduction and HACCP systems. News-O-Gram 20:16. |
| 2. | Butler, D. 1996. Novel pathogens beat food safety checks. Nature 384:397[Medline]. |
| 3. |
Centers for Disease Control and Prevention.
1997.
Escherichia coli O157:H7 infections associated with eating a nationally distributed commercial brand of frozen ground beef patties and burgers Colorado, 1997.
Morbid. Mortal. Weekly Rep.
43:777-778.
|
| 4. | Centers for Epidemiology & Animal Health. 1993. A public health concern: Escherichia coli O157:H7. Newsletter N131.0194. Centers for Epidemiology & Animal Health, Animal and Plant Health Inspection Service, U.S. Department of Agriculture Veterinary Services, Fort Collins, Colo. |
| 5. | Chapman, P. A., C. A. Siddons, P. M. Zadik, and L. Jewes. 1991. An improved selective medium for the isolation of Escherichia coli O157. J. Med. Microbiol. 35:107-110[Abstract]. |
| 6. | Chuang, K. 1995. M.S. thesis. Kansas State University, Manhattan. |
| 7. | Coombes, R. 1997. A fatal strain. Nursing Times 93(4):16-17. |
| 8. |
Farmer, J. J. I., and B. R. Davis.
1985.
H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis.
J. Clin. Microbiol.
22:620-625 |
| 9. | Fratamico, P. M., S. K. Sackitey, M. Wiedmann, and M. Y. Deng. 1995. Detection of Escherichia coli O157:H7 by multiplex PCR. J. Clin. Microbiol. 33:2188-2191[Abstract]. |
| 10. | Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli and the associated hemolytic uremic syndrome. Epidemiol. Infect. 113:199-207. |
| 11. | Gunzer, F., H. Bohn, and H. Russman. 1992. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic uremic syndrome. Infect. Immun. 30:1807-1810. |
| 12. | He, Y., J. E. Keen, R. B. Westerman, E. T. Littledike, and J. Kwang. 1996. Monoclonal antibodies for detection of the H7 antigen of Escherichia coli. Appl. Environ. Microbiol. 62:3325-3332[Abstract]. |
| 13. |
Huang, S. W.,
C. H. Chang,
T. F. Tai, and T. C. Chang.
1997.
Comparison of the -glucuronidase assay and the conventional method for identification of Escherichia coli on eosin-methylene blue agar.
J. Food Prot.
60:6-9.
[Medline] |
| 14. | Ingram, D. T., C. G. Rigakos, D. M. Rollins, E. T. Mallinson, L. Carr, and S. W. Joseph. 1996. Development of a 24hr assay (E. coli SELeCT) for the isolation, quantification and confirmation of E. coli O157:H7 in poultry and red meat, abstr. P-4, p. 369. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C. |
| 15. | Johnson, J. L., B. E. Rose, A. K. Sharar, G. M. Ransom, C. P. Lattuada, and A. M. McNamara. 1995. Methods used for detection and recovery of Escherichia coli O157:H7 associated with a foodborne disease outbreak. J. Food Prot. 58:597-603. |
| 16. | Johnson, R. P., R. J. Durham, S. T. Johnson, and L. A. MacDonald. 1995. Detection of Escherichia coli O157:H7 in meat by an enzyme-linked immunosorbent assay, EHEC-Tek. Appl. Environ. Microbiol. 61:386-388[Abstract]. |
| 17. | Levine, M. M., J. Xu, J. B. Kaper, H. Lior, V. Prado, B. Tall, J. Nataro, K. Helge, and K. Wachsmuth. 1987. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 156:175-182[Medline]. |
| 18. | Liddell, K. G. 1997. Escherichia coli O157:outbreak in central Scotland. Lancet 349:502-503[Medline]. |
| 19. |
March, S. B., and S. Ratman.
1986.
Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis.
J. Clin. Microbiol.
23:869-872 |
| 20. |
Okrend, A. J. G.,
B. E. Rose, and C. P. Lattuada.
1990.
Use of 5-bromo-4-chloro-3-indoxyl- -D-glucuronide in MacConkey sorbitol agar to aid in the isolation of Escherichia coli O157:H7 from ground beef.
J. Food Prot.
53:941-943.
|
| 21. | Semanchek, J. J., and D. A. Golden. 1996. Survival of Escherichia coli O157:H7 during fermentation of apple cider. J. Food Prot. 59:1256-1259. |
| 22. |
Su, C., and L. J. Brandt.
1995.
Escherichia coli O157:H7 infection in humans.
Ann. Intern. Med.
123:698-714 |
| 23. |
Toth, I.,
T. J. Barrett,
M. L. Cohen,
H. S. Rumshlag,
J. H. Green, and I. K. Wachsmuth.
1991.
Enzyme-linked immunosorbent assay for products of the 60-megadalton plasmid of Escherichia coli serotype O157:H7.
J. Clin. Microbiol.
29:1016-1019 |
| 24. | Watanabe, H., A. Wada, Y. Inagaki, K.-I. Itoh, and K. Tamura. 1996. Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet 348:831-832[Medline]. |
| 25. | Yu, H., and J. G. Bruno. 1996. Immunomagnetic-electrochemiluminescent detection of Escherichia coli O157 and Salmonella typhimurium in foods and environmental water samples. Appl. Environ. Microbiol. 62:587-592[Abstract]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |